The First Impact Factor for Translational Lung Cancer Research: 4.806

الحاوية / القاعدة Transl Lung Cancer Res (2019)

Application of the CARE guideline as reporting standard in the Translational Lung Cancer Research

الحاوية / القاعدة Transl Lung Cancer Res (2019)

Alectinib—a new chapter in the management of ALK-positive lung cancer

بواسطة Gainor, Justin F.
الحاوية / القاعدة Transl Lung Cancer Res (2016)

Dr. Viola Zhu: is ethnicity a prognostic factor in lung cancer?

بواسطة Liu, Macy
الحاوية / القاعدة Transl Lung Cancer Res (2017)

Dr. Giannis Mountzios: immunotherapy, an “earthquake” in the treatment of advanced lung cancer

بواسطة Ling, Nikki
الحاوية / القاعدة Transl Lung Cancer Res (2017)

Raising the bar: the future of EGFR inhibition in non-small lung cancer

بواسطة Redig, Amanda J.
الحاوية / القاعدة Transl Lung Cancer Res (2017)

Is more the better?—cetuximab in non-small cell lung cancer patients

بواسطة Moran, Teresa
الحاوية / القاعدة Transl Lung Cancer Res (2018)

A new era of treating advanced lung cancer is upon us

بواسطة Weiss, Glen J.
الحاوية / القاعدة Transl Lung Cancer Res (2018)

No room for statins in the quest for survival benefits in small cell lung cancer

بواسطة Facchinetti, Francesco, Tiseo, Marcello
الحاوية / القاعدة Transl Lung Cancer Res (2018)

Tobacco cessation in lung cancer screening—do we have the evidence?

بواسطة Stone, Emily, Marshall, Henry
الحاوية / القاعدة Transl Lung Cancer Res (2018)

Highlights in the 14(th) Central European Lung Cancer Conference (CELCC)

بواسطة Li, Grace
الحاوية / القاعدة Transl Lung Cancer Res (2014)

Reflections on immune checkpoint inhibition in non-small cell lung cancer

بواسطة Leventakos, Konstantinos, Mansfield, Aaron S.
الحاوية / القاعدة Transl Lung Cancer Res (2014)

Necitumumab: a new therapeutic option for squamous cell lung cancer?

بواسطة Pillai, Rathi N., Ramalingam, Suresh S.
الحاوية / القاعدة Transl Lung Cancer Res (2014)

Highlights in management of early stage non-small cell lung cancer

بواسطة Li, Grace
الحاوية / القاعدة Transl Lung Cancer Res (2013)

Erratum to current state of immunotherapy for non-small cell lung cancer

بواسطة Malhotra, Jyoti, Jabbour, Salma K., Aisner, Joseph
الحاوية / القاعدة Transl Lung Cancer Res (2017)

Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution

بواسطة Salati, Massimiliano, Baldessari, Cinzia, Cerbelli, Bruna, Botticelli, Andrea
الحاوية / القاعدة Transl Lung Cancer Res (2018)

Lung cancer and chronic obstructive pulmonary disease: understanding the complexity of carcinogenesis

بواسطة Mouronte-Roibás, Cecilia, Ruano-Raviña, Alberto, Fernández-Villar, Alberto
الحاوية / القاعدة Transl Lung Cancer Res (2018)

Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better?

بواسطة Perez-Gracia, Jose Luis, Sanmamed, Miguel F., Melero, Ignacio
الحاوية / القاعدة Transl Lung Cancer Res (2018)

Aromatase inhibitors combined with aspirin to prevent lung cancer in preclinical models

بواسطة Young, Patricia A., Pietras, Richard J.
الحاوية / القاعدة Transl Lung Cancer Res (2018)

Biomarkers in the selection of maintenance therapy in non-small cell lung cancer

بواسطة Tanner, Nichole T., Sherman, Carol A., Silvestri, Gerard A.
الحاوية / القاعدة Transl Lung Cancer Res (2012)